Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Novo Nordisk, which manufactures the popular weight-loss drug Wegovy, earlier this year paid $11 billion for three fill-finish manufacturing sites that in part will help ramp up its production of drugs to treat obesity and diabetes
Clinically this reduces dark spots, improves textural imperfections and brightens overall complexion
Biochem Pharmacol 2003;65:1483-8
Common reasons include: metabolic adaptation as the body becomes more efficient reduced calorie deficit as weight decreases appetite hormones adjusting over time changes in body composition lifestyle factors such as sleep and stress When progress slows, adjusting treatment may help support continued results
Keep meals balanced, even if smaller: Prioritise lean protein + colourful veg/fruit + calcium sources (dairy or fortified alternatives)
